Security key
74365A309
Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)
CUSIP: 74365A309
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 80,361,978
- Total 13F shares
- 1,193,025
- Share change
- +16,795
- Total reported value
- $1,298,298
- Put/Call ratio
- 16%
- Price per share
- $1.09
- Number of holders
- 27
- Value change
- +$25,721
- Number of buys
- 10
- Number of sells
- 11
Report period
Q2 2022
Institutions
27
Top holders
10
PLX full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Protalix BioTherapeutics, Inc. SEC filings
Protalix BioTherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74365A309
Recent filing periods:
Top shareholders of PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MEITAV INVESTMENT HOUSE LTD |
13F
|
Company |
0.3%
|
244,332
|
$257,000 | — | 31 Mar 2022 | |
| Phoenix Financial Ltd. |
13F
|
Company |
0.3%
|
244,113
|
$259,000 | — | 31 Mar 2022 | |
| Spire Wealth Management |
13F
|
Company |
0.19%
|
148,800
|
$158,000 | — | 31 Mar 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.18%
|
145,208
|
$154,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.14%
|
109,061
|
$116,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.07%
|
58,900
|
$62,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.05%
|
41,574
|
$44,000 | — | 31 Mar 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.04%
|
32,646
|
$35,000 | — | 31 Mar 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
28,790
|
$31,000 | — | 31 Mar 2022 | |
| IHT Wealth Management, LLC |
13F
|
Company |
0.03%
|
24,000
|
$25,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
23,867
|
$25,000 | — | 31 Mar 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
15,199
|
$16,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
12,119
|
$13,000 | — | 31 Mar 2022 | |
| Smith Salley Wealth Management |
13F
|
Company |
0.01%
|
12,048
|
$13,000 | — | 31 Mar 2022 | |
| DAVENPORT & Co LLC |
13F
|
Company |
0.01%
|
12,000
|
$13,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
11,900
|
$13,000 | — | 31 Mar 2022 | |
| Aptus Capital Advisors, LLC |
13F
|
Company |
0.01%
|
11,451
|
$12,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
6,465
|
$7,000 | — | 31 Mar 2022 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.01%
|
6,100
|
$6,000 | — | 31 Mar 2022 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.01%
|
6,000
|
$6,240 | — | 31 Mar 2022 | |
| Psagot Value Holdings Ltd. / (Israel) |
13F
|
Company |
0.01%
|
6,000
|
$6,000 | — | 31 Mar 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.01%
|
5,761
|
$6,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
5,153
|
$5,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
2,000
|
$2,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,127
|
$1,000 | — | 31 Mar 2022 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
1,100
|
$1,166 | — | 31 Mar 2022 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0%
|
800
|
$1,000 | — | 31 Mar 2022 | |
| Ten Capital Wealth Advisors, LLC |
13F
|
Company |
0%
|
790
|
$1,000 | — | 31 Mar 2022 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
500
|
$530 | — | 31 Mar 2022 | |
| Dexcel Pharma Technologies Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,637,314
|
$5,128,613 | — | 02 Jun 2021 |
Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q2 2022
As of 30 Jun 2022,
Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,193,025 shares.
The largest 10 holders included
MEITAV DASH INVESTMENTS LTD, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Spire Wealth Management, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., JANE STREET GROUP, LLC, TWO SIGMA ADVISERS, LP, CITADEL ADVISORS LLC, Virtu Financial LLC, and CAPITAL PERFORMANCE ADVISORS LLP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
28
Q2 2022 holders
27
Holder diff
-1
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.